Five prime selects BioWa and Lonza Potelligent Chok1SV
Potelligent Chok1SV which manufactures recombinant antibodies will be a host cell line. The technology will include BioWa’s glycosylation Potelligent Technology and Lonza’s GS Gene Expression System in the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.